Sandbox/v11: Difference between revisions
< Sandbox
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
Line 73: | Line 73: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 8–12 g/day IV q4–6h'''''<BR> ''OR'' <BR> ▸ '''''[[Ceftriaxone]] 2 g IV q12h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Age >50 Years}}'' | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Age >50 Years}}'' | ||
Line 83: | Line 83: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 8–12 g/day IV q4–6h'''''<BR> ''OR'' <BR> ▸ '''''[[Ceftriaxone]] 2 g IV q12h''''' | ||
|- | |- | ||
Line 98: | Line 98: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | AND | ||
Line 116: | Line 116: | ||
|} | |} | ||
<SMALL><sup>†</sup>Add | <SMALL><sup>†</sup>Add '''''[[Ampicillin]] 2 g IV q4h''''' if meningitis caused by ''[[Listeria monocytogenes]]'' is also suspected.</SMALL> | ||
====Healthcare-Associated Meningitis==== | ====Healthcare-Associated Meningitis==== |
Revision as of 19:09, 14 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Medical Therapy
Empiric Treatment
- Adjunctive dexamethasone therapy (0.15 mg/kg IV q6h for 2-4 days) is reccommended for both children and adult patients with bacterial meningitis.
Community-Acquired Meningitis
|
|
†Add Ampicillin 2 g IV q4h if meningitis caused by Listeria monocytogenes is also suspected.